HDV Screening Study

Launched by GRACE LAI HUNG WONG · Mar 17, 2025

Keywords

ClinConnect Summary

The HDV Screening Study is a research trial aimed at understanding the Hepatitis D Virus (HDV) infection in people who are also living with HIV (Human Immunodeficiency Virus) and hepatitis B (HBV). This study is open to individuals aged 18 and older who have been diagnosed with both HIV and chronic hepatitis B. Participants will be asked to provide consent to take part in the study, which is currently recruiting.

If you or a loved one qualifies, you can expect to contribute to important research that could help improve the understanding of these infections. The study will involve screening for HDV in individuals who meet the criteria, which includes having specific positive test results for HIV and hepatitis B. This is a chance to be part of a significant effort to gather information about how these diseases affect patients, and it could lead to better treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
• • 2. Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND
• • 3. Aged 18 years old or above.
• • 4. Written or verbal consent obtained
• Exclusion Criteria:
• • 1. Refusal to consent
• • 2. Age \< 18 years

Trial Officials